Mouse Drd2 Stable Cell Line - 4T1

The dopamine D2 receptor gene (Drd2) encodes a key member of the G protein-coupled receptor superfamily in mice. This receptor is primarily renowned for its potent inhibitory effect on adenylyl cyclase activity, an action that subsequently leads to a reduction in intracellular cyclic adenosine monophosphate (cAMP) concentrations. Within the murine central nervous system, the Drd2 protein is highly enriched in the striatum, olfactory tubercle, and nucleus accumbens, where it modulates a spectrum of critical physiological processes, including motor control, reward mechanisms, emotional regulation, and cognitive function. Alterations or dysfunction in Drd2 signaling are intricately linked to a diverse array of neurological and psychiatric disorders—most notably Parkinson''s disease, schizophrenia, and various forms of addiction. Beyond the central nervous system, recent scientific investigations have unveiled the significant presence and functional importance of Drd2 in peripheral tissues, including its unexpected yet pivotal role in modulating the tumor microenvironment.

The 4T1 cell line was originally isolated from a spontaneously arising mammary carcinoma in a BALB/c mouse. Widely recognized for its high tumorigenicity and invasiveness, this cell line serves as a robust model that closely recapitulates the pathophysiological characteristics of advanced human breast cancer. By genetically engineering these resilient 4T1 cells to stably express the murine Drd2 gene, researchers have established an experimental model characterized by exceptional consistency, reliability, and reproducibility. This stable cell line has undergone rigorous screening and validation to ensure that it maintains sustained and stable Drd2 expression across multiple passages, thereby effectively eliminating the issues of transient expression instability often associated with standard transfection methods. The murine Drd2-stable 4T1 cell line offers a powerful tool for delving into the increasingly evident interplay between the nervous system and tumor progression, enabling scientists to precisely dissect how dopamine signaling influences the proliferation, migration, and metastatic dissemination of breast cancer cells. Furthermore, given that 4T1 cells can be transplanted into BALB/c mice with intact immune systems, this stable cell line offers significant advantages for establishing syngeneic animal models. These in vivo models are crucial for tumor immunology research, for assessing how Drd2 modulates the local immune microenvironment, and for evaluating the efficacy of novel immunotherapies or Drd2-targeted drugs.